Trading Signals: SAGE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(SAGE Therapeutics Inc)
| SAGE latest price $78.3800 (-1.4%) ($77.2500 - $80.4800) on Wed. Nov. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.17% (three month average) | RSI | 68 | Latest Price | $78.3800(-1.4%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SAGE advances 5.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support SAGE advance at 0% a week (0% probability) IBB(49%) IWO(46%) IWC(43%) IWM(42%) XBI(41%) | Factors Impacting SAGE price | SAGE will decline at least -1.585% in a week (0% probabilities). VIXM(-27%) UUP(-13%) VXX(-8%) EDOC(-6%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.585% (StdDev 3.17%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $78.38(0%) | 10 Day Moving Average | $76.48(2.48%) | 20 Day Moving Average | $73.19(7.09%) | To recent high | -1.4% | To recent low | 68.3% | Market Cap | $4.071b | | | | SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. |